154 related articles for article (PubMed ID: 34610043)
1. Factors affecting the follow-up time after a positive result in the fecal occult blood test.
Cheng YW; Li YC
PLoS One; 2021; 16(10):e0258130. PubMed ID: 34610043
[TBL] [Abstract][Full Text] [Related]
2. Examining the Factors That Affect the Diagnosis of Patients with Positive Fecal Occult Blood Test Results.
Cheng YW; Li YC
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805251
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
[TBL] [Abstract][Full Text] [Related]
4. Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.
Ciatto S; Castiglione G
Tumori; 2002; 88(2):95-8. PubMed ID: 12088265
[TBL] [Abstract][Full Text] [Related]
5. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
[TBL] [Abstract][Full Text] [Related]
7. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
[TBL] [Abstract][Full Text] [Related]
8. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.
Singh H; Kadiyala H; Bhagwath G; Shethia A; El-Serag H; Walder A; Velez ME; Petersen LA
Am J Gastroenterol; 2009 Apr; 104(4):942-52. PubMed ID: 19293786
[TBL] [Abstract][Full Text] [Related]
9. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening, comorbidity, and follow-up in elderly patients.
Garman KS; Jeffreys A; Coffman C; Fisher DA
Am J Med Sci; 2006 Oct; 332(4):159-63. PubMed ID: 17031239
[TBL] [Abstract][Full Text] [Related]
13. Barriers to full colon evaluation for a positive fecal occult blood test.
Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
15. A national survey of primary care physicians' methods for screening for fecal occult blood.
Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
[TBL] [Abstract][Full Text] [Related]
16. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
[TBL] [Abstract][Full Text] [Related]
17. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
18. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
[TBL] [Abstract][Full Text] [Related]
19. Cancer screening before and after switching to a high-deductible health plan.
Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
[TBL] [Abstract][Full Text] [Related]
20. Predictors of colorectal cancer screening in diverse primary care practices.
Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]